Dinesh Kashyap

Dinesh Kashyap

FDA Chooses Box for Cloud Content Management1 min read

The U.S. Food and Drug Administration (FDA) has reportedly selected Box’s cloud content management platform to modernize its technical infrastructure and drive new ways to work in the cloud. With Box, the FDA is furthering its IT innovation strategy to digitize business processes and envision new ways to engage with the pharmaceutical and life sciences industry.

FDA IT leadership, tasked with modernizing its technology infrastructure and re-imagining how the FDA works with the life sciences industry, selected Box to:

• Improve external collaboration with third party organizations, including external experts, and supporting audits, discoveries and reviews;
• Digitize and automate processes leveraging Box as a central content portal where staff can easily collaborate and share materials internally and with external parties;
• Reduce complexity of infrastructure by eliminating fragmented content and document management tools; and
• Provide the FDA with added cybersecurity control and administrative capabilities necessary to govern and protect sensitive information at scale.
Cloudbyz has built electronic trial master file (eTMF) to collaborate in clinical research between sponsors, CRO and clinical sites. Cloudbyz eTMF leverages Box to store content. Cloudbyz eTMF creates TMF folder structure with button and enables better organization of content as per DIA TMF structure.

Credit: clinical informatics news



Related Blog​s

Clinical Trial Budget Management
Mythri Raghunandan

Five Key Challenges to Site Payments

Sites play a very critical role in Clinical Trials and it’s very important that they get paid in a timely manner for the services they render. However, numerous surveys have shown that sites participating in studies face huge challenges related to timely payments leading to low satisfaction scores by sites on Sponsors and CROs.

Read More »
Abhijit Joshi

How Clinical Trial Sponsors Can Help During the Spread of COVID-19

As the spread of COVID-19 has affected every industry, pharmaceutical and biotech companies are feeling the heat of it. In our last piece, we covered some of the issues the clinical trial industry, as a whole, was facing. With unexpected delays, over-flooded inboxes, and patient safety at risk, here are specific ways sponsors can and are alleviating the negative impact of the virus…

Read More »
Patient Recruitment
Mythri Raghunandan

Cloudbyz – Safety – Pharmacovigilance Solution

Pharmacovigilance is a continuous process of collection and analysis of data relating to the detection, assessment, understanding, and prevention of adverse events of medicines and medical devices. Pharmacovigilance is critical for the Healthcare industry for approval of new drugs and devices and to further promote

Read More »

©2020 Cloudbyz Inc. All Rights Reserved.